Propharma
Propharma Group, a leading provider in the pharmaceutical services industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1998, the company has established itself as a trusted partner in drug development and commercialisation, offering a comprehensive suite of services that includes regulatory affairs, quality assurance, and clinical trial management. Propharma Group is renowned for its commitment to quality and compliance, ensuring that clients navigate the complexities of the pharmaceutical landscape effectively. With a strong market position, the company has achieved significant milestones, including numerous successful product launches and partnerships with major pharmaceutical firms. Its unique blend of expertise and innovative solutions positions Propharma Group as a pivotal player in enhancing patient access to vital medications.
DitchCarbon Score
How does Propharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Propharma's score of 10 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Propharma's reported carbon emissions
In 2022, Propharma reported total carbon emissions of approximately 740,400 kg CO2e from Scope 1 and 14,500 kg CO2e from Scope 2. This reflects a slight decrease from 2021, where emissions were about 741,000 kg CO2e for Scope 1 and 12,600 kg CO2e for Scope 2. Propharma has committed to achieving net-zero emissions across all scopes by 2050, with a start year of 2023. This long-term target aligns with the Science Based Targets initiative (SBTi), demonstrating their dedication to reducing their carbon footprint in the professional services sector. As a company headquartered in the United States, Propharma is actively engaging in climate action, focusing on both immediate and long-term strategies to mitigate their environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 741,000 | 000,000 |
| Scope 2 | 12,600 | 00,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Propharma is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
